Cabaletta Bio, Inc. (CABA) vs C4 Therapeutics, Inc. (CCCC)
A side-by-side comparison of Cabaletta Bio, Inc. and C4 Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CABA
Cabaletta Bio, Inc.
$2.01HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
CCCC
C4 Therapeutics, Inc.
$2.89HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — CABA vs CCCC
growth of $100 · dividends reinvested · last 6yCABA -78.8% (-22.8%/yr)CCCC -88.3% (-30.0%/yr)CABA compounded faster over this window
CABA CCCC
CABA vs CCCC: by the numbers
- •CABA is the larger company ($328M vs $319M market cap).
- •Both run net losses; CABA's is the smaller (0.00% vs -289.44% net margin).
Metrics side by side
Valuation
| Metric | CABA | CCCC |
|---|---|---|
| P/S ratio | N/A | 9.11 |
| P/B ratio | 1.56 | 1.29 |
Profitability
| Metric | CABA | CCCC |
|---|---|---|
| Gross margin | 0.00% | 77.81% |
| Operating margin | 0.00% | -290.68% |
| Net margin | 0.00% | -289.44% |
| ROE | -86.10% | -41.02% |
| ROIC | -85.56% | -35.92% |
Growth (annualized)
| Metric | CABA | CCCC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 0.65% |
| Total return CAGR (5Y) | -28.71% | -41.77% |
Frequently asked
- How have CABA and CCCC total returns compared?
- Over the past 5 years, CABA delivered -28.71% and CCCC delivered -41.77% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.